These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vancomycin tolerance in methicillin-resistant Staphylococcus aureus: influence of vancomycin, daptomycin, and telavancin on differential resistance gene expression. Rose WE; Fallon M; Moran JJ; Vanderloo JP Antimicrob Agents Chemother; 2012 Aug; 56(8):4422-7. PubMed ID: 22687502 [TBL] [Abstract][Full Text] [Related]
9. Characterization of methicillin-resistant Staphylococcus aureus from skin and soft tissue infections in patients in Nairobi, Kenya. Maina EK; Kiiyukia C; Wamae CN; Waiyaki PG; Kariuki S Int J Infect Dis; 2013 Feb; 17(2):e115-9. PubMed ID: 23092752 [TBL] [Abstract][Full Text] [Related]
10. Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii. Sakoulas G; Rose W; Berti A; Olson J; Munguia J; Nonejuie P; Sakoulas E; Rybak MJ; Pogliano J; Nizet V Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872080 [TBL] [Abstract][Full Text] [Related]
11. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides. Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic susceptibility and genomic variations in Staphylococcus aureus associated with Skin and Soft Tissue Infection (SSTI) disease groups. Changchien CH; Chen SW; Chen YY; Chu C BMC Infect Dis; 2016 Jun; 16():276. PubMed ID: 27287530 [TBL] [Abstract][Full Text] [Related]
13. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Thitiananpakorn K; Aiba Y; Tan XE; Watanabe S; Kiga K; Sato'o Y; Boonsiri T; Li FY; Sasahara T; Taki Y; Azam AH; Zhang Y; Cui L Sci Rep; 2020 Sep; 10(1):16107. PubMed ID: 32999359 [TBL] [Abstract][Full Text] [Related]
14. Quorum Sensing, Virulence, and Antibiotic Resistance of USA100 Methicillin-Resistant Staphylococcus aureus Isolates. Grundstad ML; Parlet CP; Kwiecinski JM; Kavanaugh JS; Crosby HA; Cho YS; Heilmann K; Diekema DJ; Horswill AR mSphere; 2019 Aug; 4(4):. PubMed ID: 31413175 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Sakoulas G; Moise PA; Casapao AM; Nonejuie P; Olson J; Okumura CY; Rybak MJ; Kullar R; Dhand A; Rose WE; Goff DA; Bressler AM; Lee Y; Pogliano J; Johns S; Kaatz GW; Ebright JR; Nizet V Clin Ther; 2014 Oct; 36(10):1317-33. PubMed ID: 25017183 [TBL] [Abstract][Full Text] [Related]
16. Novel Daptomycin Tolerance and Resistance Mutations in Methicillin-Resistant Staphylococcus aureus from Adaptive Laboratory Evolution. Sulaiman JE; Lam H mSphere; 2021 Oct; 6(5):e0069221. PubMed ID: 34585959 [TBL] [Abstract][Full Text] [Related]
17. Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients. Mishra NN; Bayer AS; Moise PA; Yeaman MR; Sakoulas G J Infect Dis; 2012 Oct; 206(8):1160-7. PubMed ID: 22904338 [TBL] [Abstract][Full Text] [Related]
18. Sequential Evolution of Vancomycin-Intermediate Resistance Alters Virulence in Staphylococcus aureus: Pharmacokinetic/Pharmacodynamic Targets for Vancomycin Exposure. Lenhard JR; Brown T; Rybak MJ; Meaney CJ; Norgard NB; Bulman ZP; Brazeau DA; Gill SR; Tsuji BT Antimicrob Agents Chemother; 2015 Dec; 60(3):1584-91. PubMed ID: 26711763 [TBL] [Abstract][Full Text] [Related]
19. In vitro cross-resistance to daptomycin and host defense cationic antimicrobial peptides in clinical methicillin-resistant Staphylococcus aureus isolates. Mishra NN; McKinnell J; Yeaman MR; Rubio A; Nast CC; Chen L; Kreiswirth BN; Bayer AS Antimicrob Agents Chemother; 2011 Sep; 55(9):4012-8. PubMed ID: 21709105 [TBL] [Abstract][Full Text] [Related]
20. In vivo bioluminescence imaging to evaluate systemic and topical antibiotics against community-acquired methicillin-resistant Staphylococcus aureus-infected skin wounds in mice. Guo Y; Ramos RI; Cho JS; Donegan NP; Cheung AL; Miller LS Antimicrob Agents Chemother; 2013 Feb; 57(2):855-63. PubMed ID: 23208713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]